Pathology of rituximab-induced Kaposi sarcoma flare

BACKGROUND: Kaposi sarcoma (KS) flare may occur following therapy with corticosteroids, as part of the immune reconstitution inflammatory syndrome seen with highly active antiretroviral therapy (HAART), and after rituximab therapy. The exact mechanism responsible for iatrogenic KS flare is unclear....

Descripción completa

Detalles Bibliográficos
Autores principales: Pantanowitz, Liron, Früh, Klaus, Marconi, Sharon, Moses, Ashlee V, Dezube, Bruce J
Formato: Texto
Lenguaje:English
Publicado: BioMed Central 2008
Materias:
Research Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC2515841/
https://www.ncbi.nlm.nih.gov/pubmed/18651955
http://dx.doi.org/10.1186/1472-6890-8-7

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC2515841/
https://www.ncbi.nlm.nih.gov/pubmed/18651955
http://dx.doi.org/10.1186/1472-6890-8-7

Ejemplares similares